Novel findings on GRB2 and SOS1 could pave the way for cancer treatments

Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.

Walgreens’ new CEO slashes dividend nearly in half as stock tumbles

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) New CEO Tim Wentworth cut Walgreens’ dividend

January 5, 2024

Monthly IV version of Leqembi set for FDA review by next year – Pharmaceutical Technology

Leqembi won full FDA approval last July as a 100mg/mL injection for intravenous (IV) use as Eisai and Biogen pursue a monthly dosing regimen. Image

June 10, 2024

Nano-sized toxic metals found in cannabis vaping liquids even before the first use

Vapes have often been heralded as a “safer” way to consume either nicotine or cannabis, where legal to do so.

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.